By Tom Winnifrith, The Sheriff of AIM | Thursday 15 December 2016
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
It is now 11 days since I published details of leaked emails which showed that AIM scumbag Advanced Oncotherapy had withheld awful trading news from investors as the company launched an open offer. That is clearly securities fraud. Almost as bad, the emails showed that the timelines the company had held out to both customers in China and investors in London for product delivery were just fantasy. And that is why customers walked. Heads should have rolled. Hapless Nomad Stockdale should have forced a statement. And having told its house broker (Beaufort) that a much needed refinancing would happen by the year end, we need an update on that too. Instead...
Advanced Oncotherapy has announced "that a new video is available on the Company's website providing an inside look at the groundbreaking technical development of the LIGHT system at its testing facility in Geneva."
Bollocks. This company does not even have a working prototype (see emails HERE). How can that be called groundbreaking? It's like me claiming that I'm having sex with Cheryl Cole when we have not even had a date. Well not yet anyway, I shall come to my New Year's Resolutions later.
Advanced toerag CEO Nicholas Serandour gives it some yack and concludes "We will continue to update shareholders with further progress." In light of recent events, I doubt that very much.
The shares are 50p to sell and remain a complete stand out sell. Until this company comes clean the stock is utterly uninvestable. Meanwhile, in the absence of a statement I am not finished with this one and am preparing a Christmas Day present just for Advanced and Serandour. SELL!
Never miss a story.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Comments are turned off for this article.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen